Literature DB >> 16136704

Novel MMP inhibitor has potential for treatment of stroke.

Roxanne Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16136704     DOI： 10.1016/s1474-4422(05)70159-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  4 in total

1.  MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice.

Authors:  Peng Zhou; Nai-Cheng Song; Zhi-Kun Zheng; Yi-Qing Li; Jin-Song Li
Journal:  BMC Pulm Med       Date:  2022-06-15       Impact factor: 3.320

Review 2.  [Intracerebral hemorrhage related to anticoagulant therapy].

Authors:  H B Huttner; E Jüttler; A Hug; M Köhrmann; P D Schellinger; T Steiner
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

3.  Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke.

Authors:  V Lucivero; M Prontera; D M Mezzapesa; M Petruzzellis; M Sancilio; A Tinelli; D Di Noia; M Ruggieri; F Federico
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

4.  The Imbalance of MMP-2/TIMP-2 and MMP-9/TIMP-1 Contributes to Collagen Deposition Disorder in Diabetic Non-Injured Skin.

Authors:  Peng Zhou; Chao Yang; Shan Zhang; Zun-Xiang Ke; Dian-Xi Chen; Yi-Qing Li; Qin Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-27       Impact factor: 5.555
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.